With Scientific, Operational, and Commercial Acumen GBC Offers Practical Solutions to Turn Expertise and Innovation into Success Neil R. Mucci CEO - GBC Informed, Fast, and Adaptive Approaches to Clinical Research Studies Clinical Trial Management, Quality System Management, and Monitoring Services Biospecimen Acquisition and Biorepository Expertise Committed to Shortening Research and Development Timelines and Maximizing Client Value Accelerating the Promise of Predictive, Prognostic, Personalized, and Participatory Medicine Global BioClinical In Vitro Diagnostic Clinical Trial Services Consulting Business Clinical Trials Biospecimens NEWS OpGen Submits De Novo Request to the U.S. FDA for Unyvero Urinary Tract Infection (UTI) PanelOpGen Announces Positive Top Line Data from Clinical Trial for Unyvero Urinary Tract Infection (UTI) PanelInfanDx Tackles Early Detection of Hypoxic Ischemic EncephalopathyOpGen Subsidiary Curetis and BioVersys Sign Collaboration Agreement for Clinical Trial Support – BV100/Rifabutin to Treat Carbapenem Resistant Acinetobacter baumannii (CRAB) Infections GBC BLOG National Cancer PlanPrecision for Medicine – Biobank Partnering for Clinical Trial Assay/CDx Development and High-throughput IHC & NGS ScreeningQvin™ Diagnostic Device Receives FDA Approval in ThailandFred Hutchinson Cancer Research Center Specimen Acquisition Network (SAN) – Specimen and Data Acquisition Network Services Now Available to the University of Washington (UW) Institute of Translation Health Sciences (ITHS) Community
